{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:45:56Z","timestamp":1792273556620,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["856016-21KHRG"],"award-info":[{"award-number":["856016-21KHRG"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["KHRG2023-1037528"],"award-info":[{"award-number":["KHRG2023-1037528"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["MOP-86450"],"award-info":[{"award-number":["MOP-86450"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["MOP-97742"],"award-info":[{"award-number":["MOP-97742"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["PJ9-179813\/PJ9-184014\/PJT-186199"],"award-info":[{"award-number":["PJ9-179813\/PJ9-184014\/PJT-186199"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"DOI":"10.1007\/s00125-026-06897-x","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:55Z","timestamp":1792271275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal tubule-specific Nrf2 deletion ameliorates diabetic kidney disease by attenuating glomerular hypertension and kidney injury in a mouse model of diabetes"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8134-7310","authenticated-orcid":false,"given":"Ke","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao-Ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-8900","authenticated-orcid":false,"given":"Michifumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-4666","authenticated-orcid":false,"given":"Kana N.","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-3534","authenticated-orcid":false,"given":"Janos G.","family":"Filep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-2703","authenticated-orcid":false,"given":"Julie R.","family":"Ingelfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-6970","authenticated-orcid":false,"given":"Shao-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-454X","authenticated-orcid":false,"given":"John S. D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"10","key":"6897_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.10071\/s10157-020-01917-5","volume":"24","author":"H Kanda","year":"2020","unstructured":"Kanda H, Yamawaki K (2020) Bardoxolone methyl: drug development for diabetic kidney disease. Clin Exp Nephrol 24(10):857\u2013864. https:\/\/doi.org\/10.10071\/s10157-020-01917-5","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"6897_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000346948","volume":"37","author":"D de Zeeuw","year":"2013","unstructured":"de Zeeuw D, Akizawa T, Agarwal R et al (2013) Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON). Am J Nephrol 37(3):212\u2013222. https:\/\/doi.org\/10.1159\/000346948","journal-title":"Am J Nephrol"},{"issue":"26","key":"6897_CR3","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","volume":"369","author":"D de Zeeuw","year":"2013","unstructured":"de Zeeuw D, Akizawa T, Audhya P et al (2013) Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369(26):2492\u20132503. https:\/\/doi.org\/10.1056\/NEJMoa1306033","journal-title":"N Engl J Med"},{"issue":"12","key":"6897_CR4","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.2215\/cjn.02400222","volume":"17","author":"BA Warady","year":"2023","unstructured":"Warady BA, Pergola PE, Agarwal R et al (2023) Effects of bardoxolone methyl in Alport syndrome. Clin J Am Soc Nephrol 17(12):1763\u20131774. https:\/\/doi.org\/10.2215\/cjn.02400222","journal-title":"Clin J Am Soc Nephrol"},{"key":"6897_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ekir.2020.03.030","volume":"5","author":"M Nangaku","year":"2020","unstructured":"Nangaku M, Kanda H, Takama H et al (2020) Randomized clinical trial on the effect of bardoxolone methyl on GFR in diabetic kidney disease patients (TSUBAKI study). Kidney Int Rep 5:879\u2013890. https:\/\/doi.org\/10.1016\/j.ekir.2020.03.030","journal-title":"Kidney Int Rep"},{"issue":"6","key":"6897_CR6","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ki.1996.26","volume":"49","author":"BM Brenner","year":"1996","unstructured":"Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49(6):1774\u20131777. https:\/\/doi.org\/10.1038\/ki.1996.26","journal-title":"Kidney Int"},{"issue":"2","key":"6897_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1681\/ASN.2027121317","volume":"29","author":"RD Toto","year":"2018","unstructured":"Toto RD (2018) Bardoxolone \u2013 the phoenix? J Am Soc Nephrol 29(2):360\u2013361. https:\/\/doi.org\/10.1681\/ASN.2027121317","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"6897_CR8","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00125-018-4656-5","volume":"61","author":"C Ghezzi","year":"2018","unstructured":"Ghezzi C, Loo DDF, Wright EM (2018) Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia 61(10):2087\u20132097. https:\/\/doi.org\/10.1007\/s00125-018-4656-5","journal-title":"Diabetologia"},{"issue":"3","key":"6897_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jcph.10","volume":"58","author":"JA Brady","year":"2018","unstructured":"Brady JA, Hallow KM (2018) Model-based evaluation of proximal sodium reabsorption through SGLT2 in health and diabetes and the effect of inhibition with canagliflozin. J Clin Pharmacol 58(3):377\u2013385. https:\/\/doi.org\/10.1002\/jcph.10","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"6897_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.diabres.2012.02.022","volume":"97","author":"H Osorio","year":"2012","unstructured":"Osorio H, Coronel I, Arellano A, Franco M, Escalante B, Bautista R (2012) Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats. Diabetes Res Clin Pract 97(2):276\u2013282. https:\/\/doi.org\/10.1016\/j.diabres.2012.02.022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6897_CR11","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1038\/s41598-018-25054-y","volume":"8","author":"H Umino","year":"2018","unstructured":"Umino H, Hasegawa K, Minakuchi H et al (2018) High basolateral glucose increases sodium-glucose cotransporter 2 and reduces sirtuin-1 in renal tubules through glucose transporter-2 detection. Sci Rep 8(1):6791. https:\/\/doi.org\/10.1038\/s41598-018-25054-y","journal-title":"Sci Rep"},{"issue":"13","key":"6897_CR12","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","volume":"292","author":"XX Wang","year":"2017","unstructured":"Wang XX, Levi J, Luo Y et al (2017) SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice. J Biol Chem 292(13):5335\u20135348. https:\/\/doi.org\/10.1074\/jbc.M117.779520","journal-title":"J Biol Chem"},{"issue":"6","key":"6897_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/db20-1126","volume":"70","author":"S Zhao","year":"2021","unstructured":"Zhao S, Lo CS, Miyata KN et al (2021) Overexpression of Nrf2 in renal proximal tubular cells stimulates sodium-glucose cotransporter 2 expression and exacerbates dysglycemia and kidney injury in diabetic mice. Diabetes 70(6):1388\u20131403. https:\/\/doi.org\/10.2337\/db20-1126","journal-title":"Diabetes"},{"issue":"4","key":"6897_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM et al (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375(4):323\u2013334. https:\/\/doi.org\/10.1056\/NEJMoa1515920","journal-title":"N Engl J Med"},{"issue":"24","key":"6897_CR15","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"issue":"21","key":"6897_CR16","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMc1712572","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Matthews DR (2017) Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377(21):2099. https:\/\/doi.org\/10.1056\/NEJMc1712572","journal-title":"N Engl J Med"},{"issue":"15","key":"6897_CR17","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"key":"6897_CR18","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00004872-198909007-00002","volume":"7","author":"VJ Dzau","year":"1989","unstructured":"Dzau VJ, Ingelfinger JR (1989) Molecular biology and pathophysiology of the intrarenal renin-angiotensin system. J Hypertens Suppl 7:S3\u2013S8. https:\/\/doi.org\/10.1097\/00004872-198909007-00002","journal-title":"J Hypertens Suppl"},{"key":"6897_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1681\/ASN.2016070734","volume":"28","author":"T Yang","year":"2017","unstructured":"Yang T, Xu C (2017) Physiology and pathophysiology of the intrarenal renin\u2013angiotensin system: an update. J Am Soc Nephrol 28:1040\u20131049. https:\/\/doi.org\/10.1681\/ASN.2016070734","journal-title":"J Am Soc Nephrol"},{"key":"6897_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1172\/jci114454","volume":"85","author":"JR Ingelfinger","year":"1990","unstructured":"Ingelfinger JR, Zuo WM, Fon EA et al (1990) In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85:417\u2013423. https:\/\/doi.org\/10.1172\/jci114454","journal-title":"J Clin Invest"},{"key":"6897_CR21","doi-asserted-by":"publisher","first-page":"F435","DOI":"10.1152\/ajprenal.1995.268.3.F435","volume":"268","author":"SS Tang","year":"1995","unstructured":"Tang SS, Jung F, Diamant D et al (1995) Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am J Physiol 268:F435\u2013F446. https:\/\/doi.org\/10.1152\/ajprenal.1995.268.3.F435","journal-title":"Am J Physiol"},{"key":"6897_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/HYPERTENSIONAHA.110.163519","volume":"57","author":"LG Navar","year":"2011","unstructured":"Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA (2011) Intratubular renin\u2013angiotensin system in hypertension. Hypertension 57:355\u2013362. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.163519","journal-title":"Hypertension"},{"key":"6897_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1523-1755.1999.00271.x","volume":"55","author":"SL Zhang","year":"1999","unstructured":"Zhang SL, Filep JG, Hohman TC et al (1999) Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 55:454\u2013464. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00271.x","journal-title":"Kidney Int"},{"key":"6897_CR24","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1210\/endo.143.8.8931","volume":"143","author":"TJ Hsieh","year":"2002","unstructured":"Hsieh TJ, Zhang SL, Filep JG et al (2002) High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143:2975\u20132985. https:\/\/doi.org\/10.1210\/endo.143.8.8931","journal-title":"Endocrinology"},{"key":"6897_CR25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/sj.ki.5000210","volume":"69","author":"S Sachetelli","year":"2006","unstructured":"Sachetelli S, Liu Q, Zhang SL et al (2006) RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69:1016\u20131023. https:\/\/doi.org\/10.1038\/sj.ki.5000210","journal-title":"Kidney Int"},{"key":"6897_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1681\/asn.2007010074","volume":"19","author":"F Liu","year":"2008","unstructured":"Liu F, Brezniceanu ML, Wei CC et al (2008) Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 19:269\u2013280. https:\/\/doi.org\/10.1681\/asn.2007010074","journal-title":"J Am Soc Nephrol"},{"key":"6897_CR27","doi-asserted-by":"publisher","first-page":"F840","DOI":"10.1152\/ajprenal.00340.2011","volume":"302","author":"CS Lo","year":"2012","unstructured":"Lo CS, Liu F, Shi Y et al (2012) Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am J Physiol Renal Physiol 302:F840\u2013F852. https:\/\/doi.org\/10.1152\/ajprenal.00340.2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"6897_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1042\/cs20210094","volume":"135","author":"KN Miyata","year":"2021","unstructured":"Miyata KN, Lo CS, Zhao S et al (2021) Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice. Clin Sci (Lond) 135:943\u2013961. https:\/\/doi.org\/10.1042\/cs20210094","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"6897_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1210\/en.2017-00752","volume":"159","author":"S Zhao","year":"2018","unstructured":"Zhao S, Ghosh A, Lo CS et al (2018) Nrf2 deficiency upregulates intrarenal angiotensin-converting enzyme-2 and angiotensin 1\u20137 receptor expression and attenuates hypertension and nephropathy in diabetic mice. Endocrinology 159(2):836\u2013852. https:\/\/doi.org\/10.1210\/en.2017-00752","journal-title":"Endocrinology"},{"key":"6897_CR30","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/antiox12091715","volume":"12","author":"K Su","year":"2023","unstructured":"Su K, Zhao S-L, Yang W-X et al (2023) NRF2 deficeincy attenuates diabetic kidney disease in db\/db mice via down-regulation of angiotensinogen, SGLT2, CD36, and FABP4 expression and lipid accumulation in renal proximal tubular cells. Antioxidants (Basel) 12:1715. https:\/\/doi.org\/10.3390\/antiox12091715","journal-title":"Antioxidants (Basel)"},{"key":"6897_CR31","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00125-021-05538-9","volume":"64","author":"KN Miyata","year":"2021","unstructured":"Miyata KN, Lo C-S, Zhao S et al (2021) Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes. Diabetologia 64:2589\u20132601. https:\/\/doi.org\/10.1007\/s00125-021-05538-9","journal-title":"Diabetologia"},{"issue":"3","key":"6897_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/aja.1001680308","volume":"168","author":"BA Schulte","year":"1983","unstructured":"Schulte BA, Spicer SS (1983) Histochemical evaluation of mouse and rat kidneys with lectin\u2013horseradish peroxidase conjugates. Am J Anat 168(3):345\u2013362. https:\/\/doi.org\/10.1002\/aja.1001680308","journal-title":"Am J Anat"},{"issue":"12","key":"6897_CR33","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1681\/ASN.2013010076","volume":"24","author":"J Chen","year":"2013","unstructured":"Chen J, Chen JK, Conway EM, Harris RC (2013) Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol 24(12):2023\u20132033. https:\/\/doi.org\/10.1681\/ASN.2013010076","journal-title":"J Am Soc Nephrol"},{"key":"6897_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/path.4946","volume":"243","author":"MC Liao","year":"2017","unstructured":"Liao MC, Zhao XP, Chang SY et al (2017) AT2R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression. J Pathol 243:279\u2013293. https:\/\/doi.org\/10.1002\/path.4946","journal-title":"J Pathol"},{"key":"6897_CR35","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-021-05483-7","volume":"64","author":"MC Liao","year":"2021","unstructured":"Liao MC, Pang Y-C, Chang S-Y et al (2021) AT2R deficiency accelerates podocyte dysfunction in diabetic progeny in a sex-dependent manner. Diabetologia 64:2108\u20132121. https:\/\/doi.org\/10.1007\/s00125-021-05483-7","journal-title":"Diabetologia"},{"key":"6897_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1042\/CS20220188","volume":"136","author":"M-C Liao","year":"2022","unstructured":"Liao M-C, Miyata KN, Chang S-Y et al (2022) Angiotensin type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice. Clin Sci (Lond) 136:715\u2013731. https:\/\/doi.org\/10.1042\/CS20220188","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"6897_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2337\/db24-0553","volume":"74","author":"W-X Yang","year":"2025","unstructured":"Yang W-X, Su K, Liao M-C et al (2025) Renal tubule-specific angiotensinogen deletion attenuates SGLT2 expression and amerliorates diabetic kidney disease in murine models of type 1 diabetes. Diabetes 74(4):554\u2013568. https:\/\/doi.org\/10.2337\/db24-0553","journal-title":"Diabetes"},{"key":"6897_CR38","doi-asserted-by":"publisher","first-page":"F335","DOI":"10.1152\/ajprenal.00690.2020","volume":"321","author":"S Lan","year":"2021","unstructured":"Lan S, Yang B, Migneault F et al (2021) Caspase 3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia injury. Am J Physiol Renal Physiol 321:F335\u2013F351. https:\/\/doi.org\/10.1152\/ajprenal.00690.2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"6897_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/circulationaha.118.037418","volume":"140","author":"K Kidokoro","year":"2019","unstructured":"Kidokoro K, Cherney DZI, Bozovic A et al (2019) Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging. Circulation 140:303\u2013315. https:\/\/doi.org\/10.1161\/circulationaha.118.037418","journal-title":"Circulation"},{"key":"6897_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI8761","volume":"106","author":"S Thomas","year":"2000","unstructured":"Thomas S, Bao D, Deng A et al (2000) Adenosine formed by 5\u2032-nucleotide mediates tubuloglomerular feedback. J Clin Invest 106:289\u2013298. https:\/\/doi.org\/10.1172\/JCI8761","journal-title":"J Clin Invest"},{"key":"6897_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI4431","volume":"103","author":"J Wang","year":"1999","unstructured":"Wang J, Takeuchi T, Tanaka S et al (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic \u03b2-cell dysfunction in the Mody mouse. J Clin Invest 103:27\u201337. https:\/\/doi.org\/10.1172\/JCI4431","journal-title":"J Clin Invest"},{"issue":"1","key":"6897_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.kint.2020.07.036","volume":"99","author":"BM Rush","year":"2021","unstructured":"Rush BM, Bondi CD, Stocker SD et al (2021) Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice. Kidney Int 99(1):102\u2013116. https:\/\/doi.org\/10.1016\/j.kint.2020.07.036","journal-title":"Kidney Int"},{"issue":"10","key":"6897_CR43","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.2337\/db13-1830","volume":"63","author":"S Abdo","year":"2014","unstructured":"Abdo S, Shi Y, Otoukesh A et al (2014) Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes 63(10):3483\u20133496. https:\/\/doi.org\/10.2337\/db13-1830","journal-title":"Diabetes"},{"issue":"12","key":"6897_CR44","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.12491022","volume":"17","author":"C Quinlan","year":"2022","unstructured":"Quinlan C, Jayasinghe K (2022) Bardoxolone methyl for Alport syndrome: opportunities and challenges. Clin J Am Soc Nephrol 17(12):1713\u20131715. https:\/\/doi.org\/10.2215\/CJN.12491022","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06897-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:56Z","timestamp":1792271276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06897-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":44,"alternative-id":["6897"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06897-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data were presented, in part, as a poster communication at the Annual Meeting of the American Society of Nephrology, Philadelphia, PA, USA, 2\u20135 November 2023, and the World Congress of Nephrology (WCN), Buenos Aires, Argentina, 13\u201316 April 2024, and as an oral communication at the Annual General Meeting of the Canadian Society of Nephrology, Quebec City, QC, Canada, 6\u20138 May 2026.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All datasets that were generated or analysed during the current study are included in the published article (and the ESM) and are available to other research groups.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This work was supported, in part, by grants from the Canadian Institutes of Health Research (PJ9-179813\/PJ9-184014\/PJT-186199 and MOP-142378 to JSDC; MOP-86450 to SLZ; MOP-97742 to JGF) and the Kidney Foundation of Canada (856016-21KHRG and KHRG2023-1037528 to JSDC). No financial arrangements were made with commercial companies. KS was the awardee of China Council Scholar in 2019 (file no. 201906275025), Department of Nephrology, Renmin Hospital of Wuhan University, Hubie, China. KNM was the recipient of Ben J. Lipps Research fellowship of the American Society of Nephrology (2019\u20132020).","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"KS drafted the manuscript. KS, JZ, SZ, YP, SYC, MCL, WXY, JP, DNL, MY and KNM contributed to the in vivo and in vitro experiments and data collection. KNM, JGF, JRI, JSDC and SLZ contributed to the discussion. JZ, YP, SYC, MCL, WXY, SZ, JP, DNL, MY, KNM, JGF, JRI, JSDC and SLZ reviewed\/edited the manuscript. All authors approved the final version for publication. The principal investigators JSDC and SLZ are co-guarantors of these data and responsible for study conception and design; as such, they had full access to all study data, take responsibility for data integrity and vouch for the accuracy of data analysis.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}